Class IIOngoing

Levothyroxine Sodium Tablets USP 150 mcg recall

FDA recall D-0403-2026 · initiated Feb 26, 2026

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Subpotent Drug

Details

Product: Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44
Recalling company: Macleods Pharms Ltd
Classification: Class II
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: Nationwide
Initiated: Feb 26, 2026
FDA report date: Apr 1, 2026

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0403-2026 ↗

← All drug recalls